Composition for treating intervertebral disc degeneration diseases, liposome nano drug delivery system and preparation method and application of liposome nano drug delivery system
A technology for degenerative diseases and drug delivery systems, applied in the field of medicine, can solve the problems of large dosage, low bioavailability, difficulty in finding a solvent solubility requirement, etc., and achieves convenient administration, improved compliance, small amount and high efficiency passive. targeted effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0024] Embodiment 1: the preparation of the liposome nano drug delivery system of the composition for the treatment of intervertebral disc degenerative disease
[0025] In this embodiment, the mass ratio of oleanolic acid to icariin is 1:10, the mass ratio of oleanolic acid to distearoylphosphatidylcholine is 1:5, and the surfactant TPGS and distearoyl The mass ratio of phosphatidylcholine is 1:8, and the mass ratio of cholesterol and distearoylphosphatidylcholine is 1:1;
[0026] Oleanolic acid, surfactant TPGS, cholesterol and distearoylphosphatidylcholine were dissolved in chloroform / ethanol solution, then rotary evaporation under reduced pressure to remove organic reagents to obtain an organic phase; icariin Dissolve in 3ml of phosphate-buffered saline buffer solution (pH6.5, concentration 10mmol / ml), add the organic phase, stir in a water bath at 60°C for 30 minutes, sonicate for 2 minutes with an ultrasonic cell pulverizer, pass through a 0.22μm filter membrane to obtain...
Embodiment 2
[0027] Embodiment 2: the preparation of the liposome nano drug delivery system of the composition for the treatment of intervertebral disc degenerative disease
[0028] In this embodiment, the mass ratio of oleanolic acid to icariin is 1:1, the mass ratio of oleanolic acid to soybean lecithin is 1:17.5, the mass ratio of surfactant TPGS to soybean lecithin is 1:29, and the mass ratio of cholesterol The mass ratio to soybean lecithin is 1:10;
[0029] Dissolve oleanolic acid, surfactant TPGS, cholesterol and soybean lecithin in chloroform / ethanol solution, then evaporate under reduced pressure to remove organic reagents to obtain an organic phase; dissolve icariin in 3ml of phosphate buffered saline Add the organic phase to the solution buffer (pH6.5, concentration 10mmol / ml), stir in a water bath at 60°C for 45 minutes, sonicate with an ultrasonic cell pulverizer for 4 minutes, and pass through a 0.22 μm filter membrane to obtain the liposome nanometer Drug system, the prepar...
Embodiment 3
[0030] Embodiment 3: the preparation of the liposome nano drug delivery system of the composition for the treatment of intervertebral disc degenerative disease
[0031] In this embodiment, the mass ratio of oleanolic acid to icariin is 10:1, the mass ratio of oleanolic acid to dipalmitoylphosphatidylcholine is 1:30, and the surfactant TPGS and dipalmitoylphosphatidylcholine The mass ratio of choline is 1:50, and the mass ratio of cholesterol and dipalmitoylphosphatidylcholine is 1:20;
[0032]Dissolve oleanolic acid, surfactant TPGS, cholesterol and dipalmitoylphosphatidylcholine in chloroform / ethanol solution, and then rotary evaporate under reduced pressure to remove organic reagents to obtain an organic phase; dissolve icariin In 3ml of phosphate-buffered saline buffer (pH6.5, concentration 10mmol / ml), add the organic phase, stir in a water bath at 60°C for 1 hour, sonicate for 6 minutes with an ultrasonic cell pulverizer, and pass through a 0.22 μm filter membrane to obtai...
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More